Mark-10 Introduces New Integrated Controls to Streamline Essential Force Measurement

Mark-10 introduces the Series F family of force testers for quality control and process monitoring in fabrication and assembly operations. The Series F family integrates IntelliMESUR software for machine control, force measurement, and data acquisition in a single clean graphical user interface. This brings another level of efficiency into recurrent testing, allowing users to define and store test sequences for both routine and unique tasks, store all measurements, and perform standard and specialized data analysis.

Mark-10 force and torque measuring instruments have long enjoyed a reputation for precision engineering and reliable operation in challenging environments. The new degree of operational simplicity in Series F force testers offers decreased test times for both routine and unique procedures to validate medical device manufacturing, measure packaging performance, confirm plastics formulation, check automotive module consistency, and verify aerospace component fabrication.

For example, medical syringe manufacturers must verify the syringe plunger force is within limits. The requirements vary with syringe geometry, so the test parameters must be adjusted for each different design. The Series F allows the full test procedure to be stored for each distinct geometry, and also allows the measured results to be correlated with syringe configuration, the plastic composition of the components, or any other elements that could influence syringe performance.

The same ease of operation and powerful data analysis can be applied to such applications as automobile seatbelt retraction force testing, package opening force verification for medication or consumer goods, and tension and compression measurements for plastic or metal test coupons for aerospace applications.

Mark Fridman, President of Mark-10, notes that the new Series F + IntelliMESUR allows more complex test sequences to be performed, without introducing more complexity for operators. “It’s more configurable, but is also easy to use. We anticipate our customers will see significant reductions in test time and cost, while having data analysis capabilities that bring added value to test operations.”

More information on the Series F + IntelliMESUR family is available at https://mark-10.com/seriesf/.

 

SourceMark-10

Hot this week

Recor Medical Reports: CMS Grants Distinct TPT Device Code and Category to Recor Medical for Ultrasound Renal Denervation

The approval of TPT offers incremental reimbursement payments for outpatient procedures performed with ultrasound renal denervation for Medicare fee-for-service beneficiaries. It becomes effective January 1, 2025, and is expected to remain effective for up to three years notes Recor Medical.

Jupiter Endovascular Reports | 1st U.S. Patient Treated with Jupiter Shape-shifting Thrombectomy Device

“Navigation challenges during endovascular procedures are often underappreciated and have led to under-adoption of life-saving procedures, such as pulmonary embolectomy. We have purpose-built our Endoportal Control technology to solve these issues and make important endovascular procedures accessible to more clinicians and their patients who can benefit from them,” said Carl J. St. Bernard, Jupiter Endovascular CEO. “This first case in the U.S. could not have gone better, and appears to validate the safety and performance we are seeing in our currently-enrolling European SPIRARE I study.”

Avery Dennison Medical Introduces Ipdated SilFoam Lite: Sustainability, MDR Certification & Performance Improvements

The newly enhanced SilFoam Lite delivers superior efficiency and reliability, bringing improved fluid handling capabilities and improved tack. These improvements make the product ideal for customers seeking quality, high-performance solutions in wound care notes Avery Dennison Medical.

Voluntary Recall Notifying Medtronic Insulin Pump Users of Potential Risks of Shortened Pump Battery Life

Medtronic plc voluntarily issued a field action starting on July 31, 2024, notifying global customers of its MiniMed™ 600 series or 700 series insulin pumps to follow their pump's built-in alerts and alarms for battery status and to contact Medtronic if they observe changes in the battery life of their pump

Medtronic Expands AiBLE Spine Surgery Ecosystem with New Technologies and Siemens Healthineers Partnership

New advancements in the AiBLE Spine Surgery ecosystem build upon the company's commitment to procedural innovation and execution